IFN-γ/IL-2 Double-Color FluoroSpot Assay for Monitoring Human Primary T Cell Activation: Validation, Inter-Laboratory...

Area of Science:

• Immunology
• Bioanalytical Method Validation

Background:

• Enzyme-linked immunosorbent spot (EliSpot) and FluoroSpot assays are sensitive tools for quantifying immune cells.
• These assays are crucial in clinical trials for evaluating immunotherapies and vaccines.
• Formal industry guidance for validating these assays is lacking.

Purpose of the Study:

• To describe a comprehensive in vitro validation of a double-color FluoroSpot assay.
• To establish parameters for monitoring antigen-specific lymphocytes (IFN-γ and IL-2 production).
• To ensure assay performance meets regulatory standards for clinical trial immune monitoring.

Main Methods:

• Validation of a double-color FluoroSpot assay using human peripheral blood mononuclear cells (PBMCs) and model antigens.
• Determination of validation parameters including limit of detection (LOD) and limits of quantification (LLOQ/ULOQ).
• Assessment of assay precision, specificity, linearity, robustness, and inter-laboratory concordance.

Main Results:

• Established validation parameters and acceptance criteria for the FluoroSpot assay.
• Demonstrated assay performance through precision, specificity, linearity, and robustness testing.
• Confirmed inter-laboratory concordance, indicating reliable results across different settings.

Conclusions:

• The study outlines a robust approach for validating EliSpot and FluoroSpot assays.
• The validated IFN-γ/IL-2 FluoroSpot assay is suitable for reliable detection of antigen-specific immune responses.
• The assay meets current regulatory requirements for bioanalytical method validation in clinical trials.